Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Nov 13, 2017

Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

Nov 10, 2017

Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE)

Nov 09, 2017

Mylan Launches Generic Clolar® for Injection

Nov 06, 2017

Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance

Nov 01, 2017

Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)

Nov 01, 2017

Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting

Oct 31, 2017

Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint

Oct 27, 2017

Mylan's EpiPen4Schools® Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools

Oct 26, 2017

Mylan Wins UK Court Ruling Related to Copaxone® 40 mg/mL Patent

Oct 17, 2017

Mylan to Report Third Quarter 2017 Financial Results on Nov. 6, 2017

Pagination

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.